T1	Participants 53 90	men receiving finasteride for 2 years
T2	Participants 219 287	men with urodynamically documented bladder outflow obstruction (BOO)
T3	Participants 297 403	One hundred twenty-one men with benign prostatic enlargement (BPE) and lower urinary tract symptoms (LUTS)
